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Abstract
PRODH, encoding proline oxidase (POX), has been associated with schizophrenia through linkage, association, and the
22q11 deletion syndrome (Velo-Cardio-Facial syndrome). Here, we show in a family-based sample that functional
polymorphisms in PRODH are associated with schizophrenia, with protective and risk alleles having opposite effects on POX
activity. Using a multimodal imaging genetics approach, we demonstrate that haplotypes constructed from these risk and
protective functional polymorphisms have dissociable correlations with structure, function, and connectivity of striatum and
prefrontal cortex, impacting critical circuitry implicated in the pathophysiology of schizophrenia. Specifically, the
schizophrenia risk haplotype was associated with decreased striatal volume and increased striatal-frontal functional
connectivity, while the protective haplotype was associated with decreased striatal-frontal functional connectivity. Our
findings suggest a role for functional genetic variation in POX on neostriatal-frontal circuits mediating risk and protection
for schizophrenia.
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Introduction
Schizophrenia is a debilitating illness affecting about 1% of the
population with a $62.7 billion estimated economic burden in the
United States alone [1]. Twin studies and adoption studies have
shown that disease risk is largely genetic, though characterizing the
neural mechanisms underlying the disorder and mediating this
genetic risk is a challenging process. Certainly, the genetic
architecture of schizophrenia is complex and involves multiple
genes. A candidate gene for schizophrenia that has received
extensive investigation, with conflicting results, is PRODH,
encoding proline oxidase (POX). This enzyme, among other
functions, is rate limiting in the conversion of proline to glutamate
in mitochondria. PRODH along with its pseudogene are located at
22q11 is implicated in schizophrenia through a hemideletion
syndrome at this locale, 22q11 deletion syndrome (22q11DS,
Velo-Cardio-Facial syndrome, VCFS: OMIM #192430), which
may be the strongest known risk factor for schizophrenia besides
having a monozygotic twin with the disorder [2–6]. Furthermore,
a linkage peak at 22q11 has also been identified in a meta-analysis
of families with multiple affect patients with schizophrenia [7].
Several recent studies have found genetic associations of
schizophrenia with tag and functional single nucleotide polymor-
phisms (SNPs) in PRODH [8–11], although this association has not
been observed in all samples [12–18]. In addition to these genetic
data, hyperprolinemia has been noted in populations of psychotic
patients [19–26] and has been associated with neurological
problems in 22q11 syndrome [24].
Recently, Bender et al [27] in a sample of European descent
characterized several common functional genetic polymorphisms
in POX that influence a wide range of enzymatic activity from
reductions to below 30% of the reference sequence to increasing
activity to 120% of the reference sequence. These findings offer
the opportunity to study the impact of functionally characterized
variation in POX on risk for schizophrenia.
Statistical genetic association studies can provide a link between
genes and complex polygenetic constructs like mental illness, but
this approach does not illuminate the possible underlying
pathophysiology impacted or the mechanisms of association. Here
we used a staged investigation ranging from clinical genetic
association to studies of the associated pathophysiology through a
multimodal imaging approach to examine the impact of variation
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human brain of neural circuitries implicated in the pathophysi-
ology of schizophrenia. First, we identified variants in PRODH
related to risk for schizophrenia in a family-based sample. Then,
we used imaging genetic techniques to investigate genetically
correlated physiology by identifying neural systems on which these
variations impact in normal subjects who carry risk associated
alleles or haplotypes [28]. Investigating susceptibility genes in the
normal population allows for the investigation of complex trait
susceptibility alleles without confounding factors of disease, drugs
of abuse or treatment effects. In this study, we used Voxel Based
Morphometry (VBM) for whole brain quantitative structural
analysis, and a robust working memory task (NBACK) previously
shown to be sensitive to genetic variation associated with
schizophrenia susceptibility [29,30].
Results
Genetics
We found that the functional variants in PRODH were
associated with risk for schizophrenia. (Table 1) Single marker
analysis revealed that the minor allele for rs450046 was most
strongly positively associated with schizophrenia in families. This
allele has previously been associated with increased POX enzyme
activity [27]. Conversely, the minor alleles of rs4819756 and
rs2870983, linked to decreased POX activity [27], were
significantly negatively associated with schizophrenia. Three-
SNP sliding window haplotype analysis confirmed these separate
individual SNP associations by showing change from positive
associations to negative associations for haplotypes as they
differentially included the 2 functional SNPs, rs2870983 and
rs450046 separated by a tag SNP rs385440, in the 39 prime end of
the gene. The CAC haplotype at these three SNPs was positively
associated and TGT was negatively associated with schizophrenia,
as seen clearly in Table 1. Haplotype analysis comprised of the 3
functional SNPs (hereafter referred to as the ‘‘functional risk or
protective haplotypes’’) showed a significant positive disease
association with the reference alleles for rs4819756 and
rs2870983 and rs450046 minor alleles (risk haplotype: GCC)
and negative association with haplotype of the minor allele for
rs4819756 and the major alleles of rs2870983 and rs450046
(protective haplotype: ACT). In a post hoc analysis to test if the
SNPs were truly protective, we tested whether excess transmission
to unaffected siblings of schizophrenic patients was observed with
protective alleles. We found a trend for the major T allele of
rs450046 towards over transmission (z score=2.142, p=0.077).
The results of the case control analysis, comparing unaffected
siblings with unrelated controls, revealed a genotypic effect for the
protective SNP rs4819756, with a heterozygote odds ratio of 1.8
(95% C.I.1.17–2.90, OR p value=0.009) and a minor allele
homozygote odds ratio of 2.3 (95% C.I.1.26–4.27, OR p
value=0.007). There was a significant association with the
protective haplotype (ACT) and a negative association with the
reference haplotype (GCT) (Table 2).
Structural Imaging
The functional risk-associated haplotype (GCC) was associated
with reduced regional gray matter volume in the neostriatum in
the normal control sample (21, 22, 26, z=4.92, P,0.05 whole
brain corrected false discovery rate (FDR) (Figure 2 A and B). In a
post hoc exploratory analysis, the protective haplotype (ACT)
revealed a non significant trend towards gray matter volume
increase in the frontal lobes (221, 53, 8, z=3.97, P,0.001
uncorrected) (Figure 2 A and B) and occipital lobes (21,285, 17,
z=4.26, P,0.001 uncorrected) (Table S1).
Brain Function
To further characterize these findings functionally, we analyzed
the effect of the risk haplotype during working memory in the
normal sample. Network activation patterns differed, with reduced
blood oxygenation level-dependent (BOLD) signal in ventral
lateral prefrontal cortex (VLPFC, z=3.18, p,0.05 corrected) and
parietal lobes (Brodmann area (BA) 40, z=3.52, p,0.05
corrected) (Figure 2C) relative to the reference haplotype. (Table
S2) Functional connectivity for the bilateral striatal seed regions
showed trends for increased dorsal lateral prefrontal-striatal
functional connectivity (Figure 2D) for the risk haplotype carriers.
(Table S3) In contrast, the protective haplotype carriers had
decreased BOLD in bilateral striatum compared to reference
(222, 0, 12, z=3.23, p=0.05 corrected) (Figure 3D), decreased
recruitment of areas of early visual processing (BA 18, fusiform
gyrus, BA6, BA19, z=3.92, p,0.05 whole brain corrected)
(Figure 3C) (Table S4) and a decreased striatal-frontal functional
connectivity, z=3.75, p,0.037 corrected for region of interest
(ROI) (Figure 3E and F) (Table S3). Performance was not
significantly different between haplotype groups (Table S5). Post
hoc analysis including performance as a nuisance covariate had
similar activation patterns.
Control Experiment
In order to assess whether the impact on POX function is a
likely proximal cause of the systems-level findings reported above,
we performed the same set of imaging analyses with haplotypes
constructed from the 3 SNPs with no observed clinical association
or known function. These did not yield any significant genetic
effects for all phenotypes studied above.
Discussion
Using a translational approach, we show that functional
polymorphisms in PRODH, encoding POX, are linked to risk for
schizophrenia and associated with alterations in prefrontal-striatal
brain circuits involved in working memory and cognitive gating.
We found a positive disease association with the SNP previously
shown [27] to increase enzyme activity and a negative association
Author Summary
Schizophrenia is a major mental illness affecting 1% of the
population. It is known that genetics plays a role in the
disease susceptibility, and it is thought that the illness is a
complex disorder involving multiple genes. We show that
the schizophrenia susceptibility gene, PRODH, conveys its
risk through a variation that increases its enzyme activity.
We further show that protection is associated with
variations that decrease enzyme activity and these
protective variations are enriched in their unaffected
siblings. We then used brain imaging of structure and
memory function to dissect the risk and protective
haplotypes differential effects, and found that the schizo-
phrenia risk haplotype was associated with decreased
striatal gray matter volume and increased subcortical to
frontal lobe functional connectivity, while the schizophre-
nia protective haplotype was associated with trend-level
increase of frontal lobe volume and decreased subcortical
to frontal lobe connectivity. These findings indicate a new
target for treating schizophrenia and characterize associ-
ated structural and functional deficits.
PRODH and Schizophrenia Risk
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the strengths of the present study is that it assesses direct
association of multiple functional variants with disease status,
instead of relying on linkage disequilibrium (LD) between non-
functional variants and unobserved unknown variants; this is
especially important given that previous association studies did not
test multiple functional SNPs. Another advantage of this approach
particularly in this gene is that tag SNP mapping in this gene is
complicated by the presence of a pseudogene in the same
chromosomal region leading to low population SNP to SNP r
2
[31]. Additionally, in the functional assays of POX, it has been
observed that the enzymatic activity resembles the lowest activity
polymorphism when there is more than one in the haplotype [27];
therefore, without testing functional haplotypes the association
may not be observed. Despite the compelling finding that
directionality of disease association corresponded to the effects
on enzyme activity, our data do not exclude effects from variants
in long range linkage disequilibrium. However, the diminished LD
structure of this area of the genome and the results of our three
SNP sliding window analysis make this unlikely, as do the results
from our control experiment showing that nonfunctional variants
had no significant effect on brain phenotypes. We also tested post
hoc the hypothesis that putative protected alleles should be
enriched in an unaffected sibling population. Indeed, we found
that unaffected sibling status is positively associated with the POX
variants that decrease the enzyme’s activity.
Table 1. Single SNP and Haplotype Clinical Association Results.
SNP identifier Alleles MAF*
Location/Enzyme
activity FBAT Z-score ** Haplotype Functional Haplotype
rs9604911*** G/T 0.440 59 region
rs8137125*** T/G 0.208 intron 2
rs4819757*** T/C 0.166 intron 2
rs17743056 *** C/T 0.063 intron 3
rs367766*** T/C 0.115 intron 3 1.798 C
P=0.091
rs2016108*** T/C 0.402 intron 3 T
rs4819756 G/A 0.370 Exon 5 R185W 2.153 AGA
30–70% P=0.043
rs5746640*** G/A 0.438 intron 5
rs16983466*** G/A 0.159 Exon 12 D426
rs2870983 C/T 0.100 Exon 12 A472T 2.305 CT CC
,30% P=0.033
rs385440*** G/A 0.161 intron 13 22.110 AAG
P=0.024
rs450046 T/C 0.120 Exon 14 Q521R 22.409 CCT CT
120% P=0.026
rs372055*** A/G 0.350 Exon 15 L581 G
Association Positive Positive Negative Negative Positive Negative
Haplotype p value 0.007 0.03 0.019 0.01 0.007 0.022
Haplotypes Global p value 0.053 0.027 0.019 0.010 0.011 0.011
*MAF: minor allele frequency from dbSNP build 126 European population and **FBAT Z score for major allele with uncorrected P.
***Hapmap Tag SNP.
doi:10.1371/journal.pgen.1000252.t001
Table 2. Sibcentric Results.
SNP identifier FBAT* P Sib Control OR [95% CI] heterozygote Homozygote Functional Haplotype
rs4819756 1.701 0.087 1.8 [1.16–2.90] 2.3 [1.26–4.27] G A
P=0.009 P=0.007
rs2870983 CC
rs450046 2.142 0.077 TT
Z-score 22.96 2.77
Haplotype p value 0.003 0.005
Global p value 0.062 0.062
*Z-score for major allele.
doi:10.1371/journal.pgen.1000252.t002
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appreciate in the previous literature. In the original finding, Lui et
al [10] found a three SNP haplotype including one of the
functional SNPs rs450046 positively associated with schizophrenia.
Williams et al in two studies [15,16] looked first at only the 39 end
of the gene with rs383964, rs372055, and rs450046 in 677/679
case control sample from the UK and the Irish Republic and 55
trios from Bulgaria. While they tested directly the increased
enzymatic activity variant, they may not have observed positive
results due to not testing the other decreasing activity SNPs and/or
the difference in the haplotype structure in case/control sample.
Their second study [16] used a more extensive map of SNPs but
used a 368/368 case/control pooling method that would make
inferring functional haplotypes impossible. Fan et al [17] typed
rs372055 in a small Chinese family trio sample and observed no
association in their sample. Li et al [8] found rs385440 and two-
marker haplotypes consisting of rs385440 and rs450046 (G-G) and
rs372055 and rs385440 (T-A) associated with schizophrenia in a
528 trio and sibling pair sample. Abu Jamra and colleagues [18]
found no association with the three putatively non functional
SNPs, rs16983466, rs372055, and rs383964, individually or in
haplotypes in a German sample. Glaser et al [12] typed 4 SNPs
(rs450046, rs383964, rs372055 and rs385440) in a sample of 488
Bulgarian trios. They determined that only 2 SNPs could be used
by calculating r
2 in a subsample and therefore typed only rs383964
and rs372055 and were not able to find an association in their full
sample. This fact mayreflect a difference inlinkagedisequilibrium in
the greater sample or confounding by the other functional variants.
Recently in a genome wide case control association study, Sullivan
and colleagues using a large schizophrenia treatment study sample
found a positive association for one of the three SNPs in PRODH at
p=0.023, but in the setting of a genome wide association study were
unable to reach genome wide significance [11].
Our imaging findings provide further genetic evidence for
fronto-striatal loop dysfunction as part of the pathophysiology of
schizophrenia. This neural circuit has been previously defined in
the animal [32] and human [33] literature as comprised of
parallel, but interacting cortical-subcortical loops highly relevant
for sensorimotor, emotional and cognitive performance. While the
majority of our previous imaging genetic studies have focused on
cortical working memory function ‘‘inefficiency’’ signal for
increased activation of the dorsal lateral prefrontal cortex
(DLPFC) with the recruitment of the VLPFC when performance
is maintained, we are beginning to observe striatal to frontal
‘‘bottom up’’ processes also implicated in the pathophysiological
processes. We previously have shown that polymorphisms in the
PPP1R1B and in AKT1 linked to increased striatal frontal
connectivity and decreased striatal volume were associated with
genetic risk for schizophrenia [34–36]. Here, we again observe
decreased striatal gray matter volumes in carriers of the risk
haplotype in concert with increased functional connectivity with
DLPFC. Interestingly, risk haplotype carriers with evidence for
altered striatal structure and connectivity (decreased striatal
activations coupled with an increase of striatal to dorsal lateral
prefrontal functional connectivity) showed alterations in a working
memory network that suggest a decreased engagement of the
Figure 1. Genetic Association results. Above) 2ln(p) clinical results for significant SNPs and functional haplotypes. Non-synonymous functional
coding SNPs are labeled with coding changes. Exon structure is for most common transcript. Below) r
2 heat map for CBDB normal controls of
European descent as visualized in snp.plotter demonstrates the relatively low level of linkage disequilibrium across this region.
doi:10.1371/journal.pgen.1000252.g001
PRODH and Schizophrenia Risk
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coworkers, using the same functional paradigm as here in
schizophrenia, found evidence for shifts to cortically hierarchical
lower level working memory processes (the VLPFC and parietal
cortex) in the setting of DLPFC dysfunction and related to genetic
risk [37]. Tan et al (2007) further showed that an epistatic genetic
interaction of risk variants for schizophrenia involving the cortical
glutamate and dopamine systems revealed similar regions of
activation as seen here in healthy controls carrying PRODH risk
variants but in the opposite direction with the two risk variants in
COMT and GRM3 showed increased engagement of the parietal
cortex and VLPFC while PRODH risk haplotype showed an
increase in striatal activity and decrease in activation of the
parietal lobe and VLPFC [38]. This observed result may therefore
be related to the interaction of the dopamine and glutamatergic
systems through the POX enzyme but through the frontal-striatal
loops. Of note, is that PRODH haplotypes groups had no
significant performance differences and post hoc analysis including
performance as a nuisance covariate did not change the activation
patterns. Taken together, these convergent findings strongly
support the concept that altered prefrontal-striatal processing is
a genetic risk mechanism for schizophrenia [28,35].
In contrast to the risk haplotype, the protective haplotype had
opposing correlations on striatal functional connectivity (bottom-
up processing) in the performing the Nback task. In addition, the
protective haplotype was associated with trend-level increases in
frontal gray matter, a finding that is of interest since prefrontal
cortex is one of the areas in which reduced gray matter volume is
most consistently found in schizophrenia [39–43]. This finding,
however, must be viewed with caution as it did not meet stringent
statistical thresholds. If independently confirmed in future studies,
this genetic-structural association could suggest that allele-
associated increases in prefrontal grey matter volume or integrity
could contribute to a protective effect through this intermediate
phenotype. Though not hypothesized, we speculate that our
observation of increased efficiency of early visual processing areas
seen for the protective haplotype could correspond to long range
prefrontal cortex control on the early visual processing stream
previously shown to be a ‘‘top-down’’ mechanism relevant for
attentional selection [44] and therefore be related to more efficient
prefrontal control of attentional resources.
At this time, while our experiments and control experiments
suggest that it is the impact on POX function that is the proximal
event linking genetic variation in PRODH to risk for schizophrenia,
brain structure and function, the biochemical and cellular events
mediating these observations are unknown. However, several
mechanisms can be speculated about as a point of departure for
further studies. First, L-Proline can directly modulate glutamater-
gic transmission in the brain and selective expression of a brain
specific high-affinity proline transporter (SLC6A7) occurs in a
subset of glutamatergic synapses [45]. Dysfunction in glutamater-
gic neurotransmission has been widely implicated in the
pathophysiology of schizophrenia [46]. In a mouse model of type
1 hyperprolinemia, disruption of glutamatergic transmission was
observed together with altered cortical dopamine transmission and
increased catechol-o-methyltransferase gene expression [47]. The
protective SNPs decrease POX enzyme activity and may increase
levels of the precursor and possibly decrease glutamate synthesis in
Figure 2. Risk and Reference haplotypes: multimodal imaging results (see supplemental tables for results surviving multiple
comparison correction). A) Decreases in grey matter volume for risk haplotype carrier in relationship to the reference haplotype, at p,0.001
uncorrected threshold. B) Extracted striatal cluster grey matter values plotted by haplotype. C) Areas of relatively decreased BOLD signal for risk
haplotype vs. reference effect on the working memory network in normal subjects in the working memory network visualized at uncorrected
p,0.001 (VLPFC) k=13 Z=3.39, p,0.045 small volume corrected for VLPFC (45, 245, 42) k=31 Z=3.81, p,0.043 small volume corrected BA 40. Df)
Area of relatively increased and E) decreased striatal connectivity for the risk haplotype at uncorrected p,0.05. Statistical mappings are overlaid on a
single subject T1 images. Statistical results after multiple comparison correction shown in Tables S1, S2 and S3.
doi:10.1371/journal.pgen.1000252.g002
PRODH and Schizophrenia Risk
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redox shuttle in the mitochondria, while also interacting with the
intrinsic and extrinsic pathway of apoptosis [48,49]. Mitochondrial
dysfunction has been implicated in schizophrenia through
expression data [50,51] and abnormalities with redox reactions
have been associated with schizophrenia [52]. Finally, Proline is
also a recognized osmolite and it has been shown recently that
increased intracellular proline content modulates stability and
aggregation of polyglutamate proteins [53]. While the patho-
etiological evidence for a polyglutamate process in schizophrenia is
limited [54], several intracellular structural proteins have previ-
ously been associated with this disorder [55]. Molecular
mechanisms unknown at this time may also contribute to this
association, for example, serine racemase is not simply an enzyme
to produce D-serine. D-amino acid oxidase does not simply
degrade D-serine, but also degrade other D-amino acids.
Our results appear inconsistent with earlier associations of overt
hyperprolinemia and psychosis [20,21,25]. We believe this
discrepancy may be more apparent than real. Notably, blood
proline levels have a wide normal distribution [25]. We found that
common variants that would presumably translate into relative
increases of proline levels in the normal range were protective,
while risk was associated with the common variants that decreased
levels in the normal range; therefore, our results raise the
possibility that increased risk of psychosis in the context of clinical
hyperprolinemia [20,21,25] operate through different molecular
mechanisms; for example, proline’s ability to directly activate
glutamatergic NMDA receptors at extremely high levels [25] or
hypoglutamatergic neuronal state due to the lack of the metabolic
precursor, D9-pyrroline-5-carboxylic acid or other cellular role of
POX. Many other roles of POX in the cell are still being
discovered [56–58] and will been illuminating for discovering the
necessary molecular mechanism that POX increases susceptibility
for schizophrenia.
In conclusion, our data provide evidence that PRODH genetic
variations that modulate the enzymatic activity of the POX
enzyme contribute to the risk of schizophrenia through an impact
on fronto-striatal processing. Our results may offer a novel target
for the development of future therapeutic interventions.
Materials and Methods
Clinical Sample
For the genetics studies, 303 probands with schizophrenia
spectrum disorders, their unaffected siblings, their parents and 370
controls were studied as part of the Clinical Brain Disorders
Branch Sibling Study (Protocol 95-M0150, DRW PI) at the
National Institute of Mental Health. All subjects gave written
informed consent before participation in accordance to the
Internal Review Board of the NIMH. Only subjects of European
ancestry were used in the present study to minimize effects of
population stratification. An independent sample of psychiatrically
and neurologically screened healthy individuals was used for the
neuroimaging control data sets (Table S5).
Figure 3. Protective and reference haplotypes: multimodal imaging results (see supplemental tables for results surviving multiple
comparison correction). A) Increases in grey matter volume for protective haplotype carriers in relationship to reference haplotype at p,0.001
uncorrected threshold. B) Extracted values of cluster grey matter for left frontal lobe at threshold of p,0.001 as a function of protective haplotype. C)
Relatively decreased BOLD signal of early sensory processing stream for protective haplotype carriers on the working memory network in normal
subjects at FDR,0.047 full brain corrected. D) Decreased BOLD signal for protective haplotype carriers in relationship to reference haplotype, at
p,0.05 uncorrected threshold within Caudate and Putamen as defined by the Wake Forest University brain atlas. Areas of relatively E) increased and
F) decreased connectivity for protective haplotype effect at uncorrected threshold of p,0.05. Statistical mappings are overlaid on a single subject T1
images. Statistical results after multiple comparison correction shown in Tables S1, S2 and S3.
doi:10.1371/journal.pgen.1000252.g003
PRODH and Schizophrenia Risk
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4 common functional nonsynonymous SNPs and one synony-
mous SNP, previously associated with schizophrenia, were studied
(Table 1). For additional coverage of the gene, fourteen additional
tag SNPs were chosen from the Hapmap project CEU data for
NCBI build 36 (dbSNP build 126) [59]. For selection of the
tagging SNP set, we used a 2–3 SNP aggressive tagging algorithm
[60] as implemented in Haploview with minor allele frequency
.0.05 and r
2.0.80 [61]. One tag SNP failed on design of the
genotype assay, 3 tag SNPs including one functional SNP failed
due to poor amplification and one functional SNP and 3 tag SNPs
failed due to non specificity because of the pseudo-PRODH gene
detected by deviance from Hardy-Weinberg equilibrium .0.05.
Genotyping
We used standard methods to extract DNA from lymphoblastoid
cell lines using the Puregene DNA purification kit (Gentra Systems,
Minneapolis, MN). PRODH genotyping was performed using the
Taqman 59-exonuclease allelic discrimination assay [62] obtained
from Applied Biosystems (Foster City, CA) with primers and probes
sets from Assays by Design. LD mapping and association test result
plotting was performed using the R package snp.plotter [63].
Imaging Haplotype Construction
We used a Bayesian method for haplotype construction (Phase
v2.1)[64,65] using the full Caucasian normal control sample
(N=368) for the remaining 13 SNPs using 5000 iterations, one
thinning interval and a burn-in of 1000. We then recoded the
inferred haplotypes in relationship to the 3 functional SNPs;
rs450046, rs2870983 and rs4819756. 259 individuals were consid-
ered for imaging analysis if the functional haplotype were inferred at
a greater than 90 percent probability. Only the reference, risk and
one protective haplotype existed at appreciable population frequen-
cy rates .5% for haplotype imaging analysis. 17 of the 132
individualswith Nbackdata and 20 ofthe 124 individualswith VBM
data were excluded due to missing data of a functional SNP which
resulted in ambiguous haplotype assignment.
As a control experiment, to ascertain whether the impact on
POX function is a likely contributor to our findings, we performed
this procedure for three SNPs that had no clinical association, no
known function (in particular, no impact on POX activity) and
r
2,0.2 with any known functional SNP, rs9604911, rs17743056,
and rs5746640 and analyzed these haplotypes exactly as stated
above. 64 individuals were used in the VBM analysis and 55 were
used in the Nback analysis.
Genetic Association
Family-based association testing was done via FBAT for single
SNPs, 3-SNP sliding window haplotypes and haplotypes com-
prised of the three functional SNPs. All p-values were obtained via
permutation testing using 1,000 replicates and are not adjusted for
multiple testing.
If the protective haplotype decreases risk for schizophrenia, it
should be overtransmitted from the parents to unaffected siblings of
schizophrenia. Therefore, we additionally performed a post hoc
‘‘sibcentric’’ analysis, by considering the transmissions to the
unaffected siblings to be the ‘‘case’’ and non-transmission of parental
alleles to be ‘‘pseudocontrols’’ of interest using FBAT (n=235
families) and also examined them in a logistic regression using only
one unaffected sibling per family single functional SNP genotypic
case/control (n=167/350) method in STATA and with a 3 SNP
functional haplotype analysis using the R package haplo.stats [66].
Structural MRI
For structural analysis, scans for 92 individuals passed quality
control and also had usable genotypes. Of those, 39 subjects were
included in the risk compared to reference haplotype analysis and
85 subjects were included in the protective compared to reference
haplotype analysis, Table S5. Structural scans were performed on
a 1.5 T GE scanner (General Electric, Milwaukee, WI) using a T1-
weighted SPGR sequence (repetition time, 24 msec; echo time,
5 msec, 2566256; field of view, 24624 cm; flip angle 45u), with
124 sagittal slices at a thickness of 1.5 mm and an in-plane
resolution of 0.9460.94 mm. Optimized VBM [67,68] was
performed using custom templates in SPM2 http://www.fil.ion.
ucl.ac.uk/spm/; (Wellcome Department of Imaging Neuroscience,
London, UK) as previously described [69]. Modulated and
segmented grey matter images were smoothed with a 12-mm
Gaussian kernel prior to statistical analysis.
Functional Neuroimaging
The Nback task has been shown to reliably activate the working
memory network in normal subjects, shows an abnormal pattern in
schizophrenia patients and their healthy relatives and is sensitive to
genetic variation [30,70]. Briefly, we used a block design version of
the Nback task where 100% of stimuli were both target and probes.
A 0-back control task block where the subject simply responded with
the current digit presented (1–4 in a diamond shaped box) was
alternating with the 2-back block in which the subject serially
responded with numbers presented 2 previous (‘‘n’’=2). Data were
availablefor 108 subjects.48 subjects were used inthe riskcompared
to reference haplotype analysis and 103 subjects were used in the
protective compared to reference haplotype analysis (Table S5).
BOLD fMRI was performed on a GE Signa 3-T scanner using
gradient echo EPI (24 axial slices, 6 mm thickness, 1 mm gap, TR/
TE=2000/28 ms, FOV=24 cm, matrix=64664). Images were
processed on the first level using SPM99 with a 2.0b a c kc o n t r a s t .
Functional Connectivity Analysis
Based on structural findings of the risk haplotype, which
identified striatum, prefrontal connectivity with striatum was
characterized using BOLD response maps with the Nback task by
computing functional connectivity, as described previously [35].
Briefly, seed ROI for functional connectivity were placed within
the combined bilateral caudate, head and body, and putamen as
defined in the Wake Forest University brain atlas (WFU) (www.
fmri.wfubmc.edu) [71], and median BOLD time course in these
regions were then correlated across all voxels, yielding a map of
correlation coefficients in every voxel with the seed region activity.
These functional correlation maps were then analyzed in a
random-effects model in SPM for haplotype effects as below.
Second Level Analysis
Second level linear regression analyses as implemented using the
general linear model in SPM2 of structural data and SPM99 for
functional data [72]. Imputed PRODH haplotypes were covariates
of interest entered into the model with the following nuisance
covariates: for VBM: gender, total gray matter volume, age, and
second-order polynomial age expansions and for Nback: age and
gender. For all analyses, a stringent threshold of p,0.05, corrected
for multiple comparisons using false discovery rate, was used,
either for whole brain or small volume corrected for a priori
hypothesized ROI. ROI analysis for the Nback was based on
known regions involved in functional compensatory mechanisms
during Nback working memory as previously described in Tan et
al. [37] and regions engaged in gene6gene interaction of
PRODH and Schizophrenia Risk
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bilateral striatum ROI constructed as above was used to examine
haplotype dependent BOLD signal. Based on our previous genetic
findings [35] for striatal frontal connectivity, analysis was restricted
to ROI of dorsal lateral prefrontal cortex (DLPFC BA 45, 46, 9).
We have recently shown that this methodology affords excellent
protection against false positives in imaging genetics [74].
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